Eden Research plc Issuing of Annual Report & Notice of AGM (2714W)
April 16 2019 - 2:01AM
UK Regulatory
TIDMEDEN
RNS Number : 2714W
Eden Research plc
16 April 2019
16 April 2019
Eden Research plc
("Eden" or "Company)
Issuing of Annual Report & Notice of AGM
Eden Research plc (AIM: EDEN), the AIM listed company that
develops and supplies breakthrough biopesticide products and
natural microencapsulation technologies to the global crop
protection, animal health and consumer products industries,
announces that its Annual Report and Accounts for the year ended 31
December 2018, Notice of the Annual General Meeting ("AGM") and a
Form of Proxy have been issued to shareholders and are now
available on the Company's website: www.edenresearch.com
The AGM is to be held on Tuesday 14(th) May at 1.00pm at the
Institute of Directors, 116 Pall Mall, London SW1Y 5ED.
For further information contact:
Eden Research plc www.edenresearch.com
Sean Smith
Alex Abrey 01285 359 555
Shore Capital (Nomad) 020 7408 4090
Stephane Auton / Patrick Castle
Powerscourt (Financial PR) 020 7250 1446
Nick Dibden/Jana Tsiligiannis
Notes:
Eden Research is a technology development and commercialisation
company with intellectual property and expertise in encapsulation,
terpenes and environmentally friendly technologies to provide
naturally occurring solutions for the global agrochemicals, animal
health, and consumer product industries.
Eden's encapsulation technology harnesses the biocidal efficacy
of naturally occurring chemicals produced by plants (terpenes) and
can also be used with both natural and synthetic compounds to
enhance their performance and ease-of-use. The technology uses
yeast cells that are a by-product of numerous commercial production
processes to deliver a slow release of natural compounds for
agricultural and non-agricultural uses. Terpenes are already widely
used in the food flavouring, cosmetics and pharmaceutical
industries.
Historically, terpenes have had limited commercial use in the
agrochemical sector due to their volatility, phytotoxicity and poor
solubility. Eden's platform encapsulation technology provides a
unique, environmentally friendly solution to these problems and
enables terpenes to be used as effective, low-risk
agrochemicals.
Eden is developing these technologies through innovative
research and a series of commercial production, marketing and
distribution partnerships.
The Company has a number of patents and a pipeline of products
at differing stages of development targeting specific areas of the
global agrochemicals industry. To date, the Company has invested in
the region of GBP13m in developing and protecting its intellectual
property and seeking regulatory approval for products that rely
upon the Company's technologies. Revenues earned by the Company to
date have been modest whilst the Company has concentrated on
securing patent protection for its intellectual property, gaining
regulatory approvals, identifying suitable industrial partners, and
entering into commercial agreements.
In May 2013, the three actives that comprise Eden's first
commercial product, 3AEY, were approved as new ingredients for use
in plant protection products. This represented a major milestone in
the commercialisation of Eden's technology and is a significant
accomplishment for any company. To illustrate this point, it should
be noted that in all of 2013 Eden's approvals represented 3 of only
10 new active ingredients approved by the EC.
3AEY has been authorised for sale in Kenya, Malta, Greece,
Bulgaria, Spain, Italy, France, Cyprus, Albania, Portugal and the
Republic of Macedonia.
Eden was admitted to trading on AIM on 11 May 2012 and trades
under the symbol EDEN.
For more information about Eden, please visit:
www.edenresearch.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCZMGMDMKKGLZZ
(END) Dow Jones Newswires
April 16, 2019 02:01 ET (06:01 GMT)
Eden Research (LSE:EDEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eden Research (LSE:EDEN)
Historical Stock Chart
From Sep 2023 to Sep 2024